Platform Incorporating Patient Navigation, Preparative Guidelines, and Hospital at Home May Improve COVID-19 Outcomes for Patients with Myeloid Malignancies

Background: Patients (pts) with malignancies are at increased risk of morbidity and mortality from COVID-19. Among these pts, some of the higher case fatality ratios (CFR) reported are among pts with myeloid malignancies, ranging from 37 to 50% (Mehta V, Cancer Discov 2020; Ferrara F, Leukemia 2020)...

Descripción completa

Detalles Bibliográficos
Autores principales: Ragon, Brittany Knick, Moyo, Tamara K., Sumrall, Ashley, Osunkwo, Ifeyinwa (IFY), Blackley, Kris, Kabrich, Laura, Leonard, Kelly A., Masten, Ben, York, Beth, Murphy, Stephanie, Kersten, Brian, Batchelor, Thomas, Rivet, Carly, Parala-Metz, Armida, Shahid, Zainab, Chai, Jean, Musselwhite, Laura, Shah, Nilay A., Sanikommu, Srinivasa Reddy R., Chojecki, Aleksander L., Knight, Thomas G., Ai, Jing, Avalos, Belinda R, Grunwald, Michael R., Copelan, Edward A., Walsh, Declan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology. Published by Elsevier Inc. 2021
Materias:
903.Health Services Research-Myeloid Malignancies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8701538/
http://dx.doi.org/10.1182/blood-2021-150610

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8701538/
http://dx.doi.org/10.1182/blood-2021-150610

Ejemplares similares